Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life
- PMID: 27335961
- PMCID: PMC4784590
- DOI: 10.1177/2333794X15590149
Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life
Abstract
Botulinum neurotoxins are natural molecules produced by anaerobic spore-forming bacteria called Clostradium boltulinum. The toxin has a peculiar mechanism of action by preventing the release of acetylcholine from the presynaptic membrane. Consequently, it has been used in the treatment of various neurological conditions related to muscle hyperactivity and/or spasticity. Also, it has an impact on the autonomic nervous system by acting on smooth muscle, leading to its use in the management of pain syndromes. The use of botulinum toxin in children separate from adults has received very little attention in the literature. This review presents the current data on the use of botulinum neurotoxin to treat various neurological disorders in children.
Keywords: botulinum toxin; children; neurological uses.
Conflict of interest statement
References
-
- Johnson EA, Montecucco C. Botulism. In: Engel Andrew G, ed. Handbook of Clinical Neurology. Amsterdam, Netherlands: Elsevier; 2008:333-368. - PubMed
-
- Montal M. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem. 2010;79:591-617. - PubMed
-
- Cherington M. Botulism: update and review. Semin Neurol. 2004;24:155-163. - PubMed
-
- Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998;129:221-228. - PubMed
-
- van Ermengem E. Uebereinenneuenanaeroben Bacillus und seine Beziehungenzum Botulismus. Zeitschrift fur Hyg und Infektionskr-ankheiten. 1897;26:1-56.
LinkOut - more resources
Full Text Sources